Two-step evolution of the hepatitis B drug-resistant mutations in a patient who developed primary entecavir resistance
Author:
Affiliation:
1. Department of Gastroenterology & Hepatology; National University Health System; Singapore
2. Yong Loo Lin School of Medicine; National University of Singapore; Singapore
3. Experimental Therapeutics Centre; Singapore
Funder
NLAM Clinician Scientist Unit
Yong Loo Lin School of Medicine
Publisher
Wiley
Subject
Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12104/fullpdf
Reference18 articles.
1. Hepatitis B virus infection: epidemiology and vaccination;Shepard;Epidemiol Rev,2006
2. A one-year trial of lamivudine for chronic hepatitis B;Lai;N Engl J Med,1998
3. No benefit to continue lamivudine therapy after emergence of YMDD mutations;Liaw;Antivir Ther,2004
4. Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B;Lai;Clin Infect Dis,2003
5. Antiviral drug-resistant HBV: Standardization of nomenclature and assays and recommendations for management;Lok;Hepatology,2007
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Coevolution analysis of amino-acids reveals diversified drug-resistance solutions in viral sequences: a case study of hepatitis B virus;Virus Evolution;2020-01-01
2. Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy;Blood;2019-01-10
3. Efficacy of entecavir-based rescue therapy in lamivudine-resistant chronic hepatitis B patients in China: a retrospective study;PHARMAZIE;2018
4. Pyrosequencing method for sensitive detection of HBV drug resistance mutations;Journal of Medical Virology;2018-03-14
5. A different inhibitor is required for overcoming entecavir resistance: a comparison of four rescue therapies in a retrospective study;British Journal of Clinical Pharmacology;2017-06-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3